Nab-paclitaxel, Gemcitabine, and Bevacizumab in Advanced Malignancies

NCT01113476 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

176

Enrollment

OTHER

Sponsor class

Conditions

Advanced Cancer

Interventions

DRUG: Nab-paclitaxel
DRUG: Bevacizumab
DRUG: Gemcitabine

Sponsor

M.D. Anderson Cancer Center